Sign in
Taking peopleNo phase

Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition

Key facts

Who runs it
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Where
Mexico1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
375 people, planned
Started
1 Feb 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Isocaloric diet including chia and pumpkin seeds
  • Isocaloric diet
Record updated
14 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 28 criteriaShow less

Who can take part

  • Signing of the informed consent form
  • Both sexes
  • Adults over 18 years of age
  • BMI >18.5 kg/m2
  • Triglycerides between 200 and 500 mg/dL
  • Total cholesterol less than 240 mg/dL

Who cannot take part

  • Treatment with any medication:
  • Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or - insulin and antidiabetics
  • Treatment with statins, fibrates, or other drugs to control dyslipidemia
  • Use of steroid medications, chemotherapy, immunosuppressants, or radiation therapy
  • Treatment with any medication that influences inflammation (corticosteroids, nonsteroidal anti-inflammatory drugs, colchicine, interleukin-1 inhibitors) or triglyceride metabolism (metformin, glitazones, SGLT2 inhibitors, fibrates, statins, cholesterol ester transporter protein (CETP) inhibitors, pancreatic lipase inhibitors)
  • Previous n-3 PUFA supplementation
  • Any type of diabetes
  • kidney disease diagnosed by a physician
  • Acquired diseases that secondarily cause obesity and diabetes
  • Catabolic diseases such as cancer and acquired immunodeficiency syndrome
  • Allergy or intolerance to any food listed in the proposed pantry
  • Treatment with antihypertensive drugs (tricyclic, loop, or potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, alpha-blockers, calcium channel blockers, beta-blockers)
  • Patients who have suffered a cardiovascular event
  • Weight loss >3 kg in the last 3 months
  • Pregnancy
  • Anorectic agents or those that accelerate weight loss
  • Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel)
  • People with a smoking cessation index (SCI) greater than 21
  • People with a tobacco Index greater than 21
  • Consumption of large amounts of alcohol (14 drinks for women or 21 drinks for men in a typical week)
  • Consumption of any recreational psychoactive substance
  • Unwillingness to consume any of the foods listed in the proposed pantry

This trial is currently available in Mexico.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Hypertriglyceridemia is one of the most prevalent lipid profile disorders and is linked to a large proportion of mortality in Mexico and around the world. Various international treatment guidelines for hypertriglyceridemia have suggested the consumption of foods rich in n-3 polyunsaturated fatty acids or their intake through supplementation as a complement to lifestyle changes. However, adherence to the consumption of foods and supplements containing these fatty acids is often limited due to lack of acceptance or unaffordability. For this reason the objective of the study is to evaluate the effect of including Mexican foods rich in n-3 polyunsaturated fatty acids (chia seeds and pumpkin seeds) within a diet based on NCEP-ATPIII recommendations on triacylglycerol concentration and fatty acid profile in people with hypertriglyceridemia.

Read full original descriptionShow less

The study will consist of a 4-week period in which one group of participants will be randomized into two treatment groups: 1)isocaloric diet based on the NCEP-ATPIII dietary recommendations; 2) isocaloric diet based on the NCEP-ATPIII dietary recommendations plus chia and pumpkin seeds. The effect of the dietary intervention will be assessed by concentration of triglycerides, fatty acids profile and lipoprotein analysis.

The 2 groups in the trial

  • Isocaloric diet based on NCEP-ATPIII dietary recommendations including chia and pumpkin seeds.Treatment being tested

    Diet based on participant-specific energy expenditure. With the following macronutrient distribution: 50% carbohydrates, protein 20% and 30% fats.

    Treatment: Isocaloric diet including chia and pumpkin seeds

  • Isocaloric diet based on NCEP-ATPIII dietary recommendationsExisting treatment, for comparison

    Diet based on participant-specific energy expenditure. With the following macronutrient distribution: 50% carbohydrates, protein 20% and 30% fats.

    Treatment: Isocaloric diet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition in Individuals With Hypertriglyceridemia. Controlled Clinical Trial.
Record updated
14 April 2026